Q32 Bio Inc. financial data

Symbol
FIXX on Nasdaq
Industry
Pharmaceutical Preparations
Location
830 Winter Street, Waltham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Homology Medicines, Inc. (to 3/22/2024)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 425 % -53%
Debt-to-equity 441 % +312%
Return On Equity -572 % -150%
Return On Assets -82.6 % -93.5%
Operating Margin -8.77 K % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.9 M shares -79.3%
Common Stock, Shares, Outstanding 11.9 M shares -79.4%
Entity Public Float 45.8 M USD -50.4%
Common Stock, Value, Issued 2 K USD -66.7%
Weighted Average Number of Shares Outstanding, Basic 995 K shares +189%
Weighted Average Number of Shares Outstanding, Diluted 2.33 M shares +577%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 1.16 M USD -64%
Research and Development Expense 63.9 M USD -22%
General and Administrative Expense 33.8 M USD +28.2%
Operating Income (Loss) -109 M USD -5.69%
Nonoperating Income (Expense) 16 M USD +2900%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.1 M USD -7369%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -105 M USD -1.1%
Earnings Per Share, Basic 18.9 USD/shares
Earnings Per Share, Diluted 11.6 USD/shares +68.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 116 M USD +268%
Other Assets, Current 67 K USD
Assets, Current 138 M USD -10.1%
Property, Plant and Equipment, Net 1.66 M USD +56.2%
Operating Lease, Right-of-Use Asset 6.16 M USD -69.5%
Other Assets, Noncurrent 1.1 M USD
Assets 152 M USD -23%
Accounts Payable, Current 4.96 M USD +36.5%
Employee-related Liabilities, Current 4.41 M USD +75.1%
Accrued Liabilities, Current 19.8 M USD
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 33 M USD +78.1%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 6.1 M USD -77.8%
Other Liabilities, Noncurrent 55.1 M USD
Liabilities 104 M USD +125%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5 K USD +97.3%
Retained Earnings (Accumulated Deficit) -186 M USD +59.4%
Stockholders' Equity Attributable to Parent 48.8 M USD
Liabilities and Equity 152 M USD -23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.6 M USD -16.4%
Net Cash Provided by (Used in) Financing Activities 99.3 M USD +662207%
Net Cash Provided by (Used in) Investing Activities 101 M USD +176%
Common Stock, Shares Authorized 400 M shares +100%
Common Stock, Shares, Issued 11.9 M shares -79.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.28 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 116 M USD +213%
Deferred Tax Assets, Valuation Allowance 221 M USD +23.2%
Deferred Tax Assets, Gross 222 M USD +19.3%
Operating Lease, Liability 7.66 M USD -73.7%
Depreciation 574 K USD -46.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -105 M USD -0.33%
Lessee, Operating Lease, Liability, to be Paid 9.9 M USD -77.3%
Property, Plant and Equipment, Gross 2.75 M USD -63.1%
Operating Lease, Liability, Current 1.56 M USD -4.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.06 M USD -76.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.78 M USD -45%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.24 M USD -84.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09 M USD -76.8%
Deferred Tax Assets, Operating Loss Carryforwards 88.6 M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.12 M USD -76.9%
Additional Paid in Capital 235 M USD -61.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD -100%
Current Federal Tax Expense (Benefit) 0 USD -100%
Share-based Payment Arrangement, Expense 7.45 M USD -19.9%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%